|
SLC41A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.540100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.843980E-01 |
| Normal-vs-Stage2 |
2.862600E-01 |
| Normal-vs-Stage3 |
3.228400E-04 |
| Normal-vs-Stage4 |
5.822200E-04 |
| Stage1-vs-Stage2 |
7.011400E-01 |
| Stage1-vs-Stage3 |
5.463300E-03 |
| Stage1-vs-Stage4 |
6.403500E-03 |
| Stage2-vs-Stage3 |
2.588800E-01 |
| Stage2-vs-Stage4 |
2.008400E-01 |
| Stage3-vs-Stage4 |
7.419800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.235830E-02 |
| Normal-vs-AfricanAmerican |
1.642590E-03 |
| Normal-vs-Asian |
4.816800E-01 |
| Caucasian-vs-AfricanAmerican |
1.145400E-01 |
| Caucasian-vs-Asian |
8.245400E-01 |
| AfricanAmerican-vs-Asian |
7.419600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.422780E-04 |
| Normal-vs-Female |
6.927400E-01 |
| Male-vs-Female |
1.584720E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.571630E-04 |
| Normal-vs-Age(41-60Yrs) |
9.796900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.578080E-02 |
| Normal-vs-Age(81-100Yrs) |
6.062000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.948000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.545800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.645890E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.727400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.346400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.698960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.821000E-01 |
| Normal-vs-Grade 2 |
7.268300E-02 |
| Normal-vs-Grade 3 |
1.918480E-02 |
| Normal-vs-Grade 4 |
1.038910E-04 |
| Grade 1-vs-Grade 2 |
1.115570E-01 |
| Grade 1-vs-Grade 3 |
9.576300E-02 |
| Grade 1-vs-Grade 4 |
4.158300E-03 |
| Grade 2-vs-Grade 3 |
4.328400E-01 |
| Grade 2-vs-Grade 4 |
6.582100E-03 |
| Grade 3-vs-Grade 4 |
5.829900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.423500E-02 |
| Normal-vs-ccB subtype |
2.10369999198434E-09 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.421870E-02 |
| Normal-vs-N1 |
5.026500E-02 |
| N0-vs-N1 |
5.894800E-01 |
|
|
